Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Hypertension
Interventions
DRUG

Lisinopril

Subjects will be randomized to Low, Medium, or High dose of Lisinopril

Trial Locations (7)

10016

New York University Langone Medical Center, New York

30322

Emory University and Children's Healthcare of Atlanta, Atlanta

35233

University of Alabama, Birmingham

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48109

University of Michigan, Ann Arbor

64108

Children's Mercy Hospitals & Clinics, Kansas City

72202

Arkansas Children's Hospital, Little Rock

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

collaborator

The Emmes Company, LLC

INDUSTRY

collaborator

University of Rochester

OTHER

collaborator

OpAns, LLC

UNKNOWN

lead

Uptal Patel

OTHER

NCT01491919 - Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant | Biotech Hunter | Biotech Hunter